X4 Pharmaceuticals, Inc.
NASDAQ:XFOR
3.37 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.557 | 0 | 0 | 0 | 3 | 0 | 3.5 | 0 | 0 | 0 |
| Cost of Revenue
| 0.797 | 1.996 | 1.994 | 1.892 | 0 | 0.672 | 0.103 | 0.195 | 0.3 | 0.4 |
| Gross Profit
| 1.76 | -1.996 | -1.994 | -1.892 | 3 | -0.672 | 3.397 | -0.195 | -0.3 | -0.4 |
| Gross Profit Ratio
| 0.688 | 0 | 0 | 0 | 1 | 0 | 0.971 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 81.643 | 70.021 | 61.058 | 50.647 | 41.932 | 30.163 | 30.979 | 28.128 | 17.831 | 12.706 |
| General & Administrative Expenses
| 0 | 0 | 0 | 24.702 | 20.942 | 17.64 | 18.406 | 8.005 | 6.515 | 2.119 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 61.518 | 35.505 | 27.02 | 24.702 | 20.942 | 17.64 | 18.406 | 8.005 | 6.515 | 2.119 |
| Other Expenses
| -105 | 0 | -6.27 | -3.572 | -2.109 | -1.104 | -0.085 | -0.016 | 0.104 | -0.077 |
| Operating Expenses
| 38.161 | 107.522 | 88.078 | 75.349 | 62.874 | 47.803 | 46.206 | 32.265 | 21.956 | 12.67 |
| Operating Income
| -36.401 | -107.522 | -87.569 | -85.107 | -59.874 | -51.703 | -45.885 | -36.133 | -24.346 | -14.825 |
| Operating Income Ratio
| -14.236 | 0 | 0 | 0 | -19.958 | 0 | -13.11 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.739 | 6.433 | -6.27 | -3.572 | -2.109 | -1.104 | 2.864 | 2.256 | 6.481 | 1.607 |
| Income Before Tax
| -37.14 | -101.089 | -93.839 | -88.679 | -61.983 | -52.807 | -43.021 | -33.877 | -22.975 | -13.218 |
| Income Before Tax Ratio
| -14.525 | 0 | 0 | 0 | -20.661 | 0 | -12.292 | 0 | 0 | 0 |
| Income Tax Expense
| 0.31 | 0.078 | 0.028 | 0.017 | 0.148 | 3.797 | 3.903 | 1.868 | 2.619 | 0.395 |
| Net Income
| -37.45 | -101.167 | -93.867 | -88.696 | -62.131 | -56.604 | -43.021 | -33.877 | -22.975 | -13.218 |
| Net Income Ratio
| -14.646 | 0 | 0 | 0 | -20.71 | 0 | -12.292 | 0 | 0 | 0 |
| EPS
| -0.186 | -0.57 | -1.52 | -3.99 | -3.09 | -4.63 | -79.1 | -54.57 | -4.38 | -0.47 |
| EPS Diluted
| -0.186 | -0.57 | -1.52 | -3.99 | -3.09 | -4.63 | -79.1 | -54.57 | -4.38 | -0.47 |
| EBITDA
| -27.576 | -107.103 | -87.569 | -85.107 | -58.065 | -51.703 | -45.885 | -31.603 | -20.16 | -12.346 |
| EBITDA Ratio
| -10.785 | 0 | 0 | 0 | -19.355 | 0 | -13.11 | 0 | 0 | 0 |